What is the market capitalization of VolitionRX Limited?

VolitionRX Limited (VNRX) has a market capitalization of approximately 17,326,962 USD.

Where can I buy VNRX in Canada?

VNRX can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

VNRX

VolitionRX Limited

VolitionRX Limited (VNRX) is an American company in the healthcare sector, listed on AMEX. Market capitalization of 17 million USD (micro-cap).

Details

Price2.08 USD

Market cap17.33 M USD

Payout ratio0.00%

SectorHealthcare

Websitevolition.com

Updated 4h ago

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.